Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlgoDx
Stockholm, Stockholm County, Swedenalgodx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NAVOY CDS, the company’s flagship product, is an FDA-cleared and EU/UK-approved machine learning-based software that provides early warnings of sepsis in hospitalized patients. It leverages routinely collected vital parameters to predict risk and enable earlier intervention. The tool is already in commercial use and aims to improve patient outcomes by enabling timely treatment of sepsis.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Software as a Medical Device (SaMD)Clinical decision support software
- Industry
- Digital Health Medical Devices
02
Partnerships
EIT HealthBrigham and Women’s Hospital / Harvard Medical School collaboration via board chair Dr. Enrico Petrillo
Beyond the preview
Go deeper on AlgoDx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AlgoDx.